The DOI matches its Crossref record; 232 of the 244 references it cites were found in a registry or an index.
Lessons for COVID-19 Immunity from Other Coronavirus Infections
Open accessAbstract
A key goal to controlling coronavirus disease 2019 (COVID-19) is developing an effective vaccine. Development of a vaccine requires knowledge of what constitutes a protective immune response and also features that might be pathogenic. Protective and pathogenic aspects of the response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not well understood, partly because the virus has infected humans for only 6 months. However, insight into coronavirus immunity can be informed by previous studies of immune responses to non-human coronaviruses, common cold coronaviruses, and SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). Here, we review the literature describing these responses and discuss their relevance to the SARS-CoV-2 immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous experience with the closely related SARS-CoV-1, showed that CD8+ and CD4+ memory T cells were detectable as late as 17 years post-infection, while neutralizing antibody titers had waned substantially by 1 year after infection [69,70]”
From The dawn of mRNA vaccines: the COVID-19 case (2021) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,638
Research works printed but not linked: 1
- Lokugamage, 2020, SARS-CoV-2 is sensitive to type I interferon pretreatment, bioRxiv
Cited by
Sorted by citations
Items 301–319 of 319
Davis, E. H., Glass, A. M., LaBier, B. A., Tang, A., Pabon, V. B., Mayes, A. A., & Navas, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4438872/v1
Effect of infections on multiple sclerosis
Correale, J. D., & Marrodán, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823848-6.00003-8
Features of the humoral and cellular immune response to S- and N-proteins of the SARS-CoV-2 virus
Afridonova, Z. E., Топтыгина, А. П., & Mikhaylov, I. S. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524050086
Rioseras, B., Bueno‐García, E., García‐Torre, A., López‐Martínez, R., Moro‐García, M. A., Alonso, S., Menéndez-García, V., Lluna-González, A., Sousa-Fernández, A., Fernández-Gudin, M., et al. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00488-3
Antibody response after SARS-CoV-2 infection or vaccination in China: A cross-sectional study
Zhu, P., Chen, Y., Xu, X., Tan, D., Xiao, L., Liao, C.-L., Xia, H., Zhang, T., Zou, J., Chen, X., et al. (2025) · Vaccine X · doi:10.1016/j.jvacx.2025.100644
Guo, X., Zheng, H., An, Y., Song, Y., Liu, T., Zhou, Z., Liu, C.-G., Wang, G., & Wang, F. (2025) · Pharmaceuticals · doi:10.3390/ph18081216
Hiron, T. K., Falcone, S., Kipar, A., Hezzell, M., O’Callaghan, C. A., Barker, E., & Davison, L. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.679983
Lv, X.-Y., Ji, L., Cao, W., Xue, Y., Dai, H., & Zhang, S.-Z. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1657691
Yang, J., Ma, L., Guo, L., Zhang, T., Leng, Z., Jia, M., Chen, F., Qi, W., Zhang, X., Wang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329537
Yang, J., Ma, L., Guo, L., Zhang, T., Leng, Z., Jia, M., Chen, F., Qi, W., Zhang, X., Wang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329540
Unveiling the epitope repertoires and protective roles of MERS-CoV-specific T cells in mice
Zhuang, Z., Luo, J., Zhang, G., He, Y., Zhu, A., Wang, J., Wang, Y., Li, Y., Kuang, L., Chen, C., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117043
Circadian rhythm involvement in the host immune response
Diallo, A. B. (2020) · theses.fr (ABES) · doi:10.70675/d0ae13c6zedf6z402cz9fbfz469e58c326a0
Cytokine storm (septic shock and COVID-19)
Dembić, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45128-7.00006-6
Optimal Control and Cost‐Effectiveness in a Dynamic Vaccination Model for COVID‐19
Adda, R. B., & Adda, C. (2026) · International Journal of Mathematics and Mathematical Sciences · doi:10.1155/ijmm/2034556
Kinetics of immunological memory to SARS-CoV-2
Crotty, S., Sette, A., & Weiskopf, D. (2022) · ImmPort · doi:10.21430/m3s4ozjrcn
Crotty, S., Sette, A., & Weiskopf, D. (2022) · ImmPort · doi:10.21430/m31tx0gfhu
Metadata
- Authors
- Sariol, A., & Perlman, S.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Perlman, Stanley
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 53
- Issue
- 2
- Pages
- 248-263
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC7359787
- OpenAlex
- W3041450977
- Cited by
- 317
- References
- 244
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 17 · 2023: 29 · 2022: 68 · 2021: 138 · 2020: 46
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 383 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (PO1 AI060699, RO1 AI129269)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, protective immune response, SARS-CoV, MERS-CoV, common cold coronaviruses, vaccine development
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Humans, Pneumonia, Viral, Viral Vaccines, Coronavirus Infections, CD8-Positive T-Lymphocytes, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Adaptive Immunity, Pandemics, Middle East Respiratory Syndrome Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
